SCYNEXIS, Inc (SCYX) Stock Price

0.75 ▼ -0.0271 (-3.49%)
Open: 0.81 Vol: 416.69K Day's range: 0.75 - 0.8254 Feb 13, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
SCYX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL NEUTRAL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 0.78▼ 0.78▼ 0.78▼ 0.78▼ 0.74▲
MA10 0.79▼ 0.79▼ 0.79▼ 0.76▼ 0.69▲
MA20 0.79▼ 0.80▼ 0.80▼ 0.75▲ 0.69▲
MA50 0.78▼ 0.77▼ 0.77▼ 0.68▲ 0.80▼
MA100 0.76▼ 0.78▼ 0.75▲ 0.71▲ 1.18▼
MA200 0.79▼ 0.71▲ 0.69▲ 0.78▼ 1.73▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.004▼ -0.005▼ -0.005▼ 0.000▼ 0.021▲
RSI 35.404▼ 41.893▼ 42.225▼ 53.054▲ 50.174▲
STOCH 41.962     20.546     20.185     61.105     62.854    
WILL %R -100.000▼ -100.000▼ -100.000▼ -58.835     -39.145    
CCI -215.174▼ -157.140▼ -156.068▼ 35.647     128.771▲
Latest Filters Detected On SCYX
▼ MACD $SCYX MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $SCYX Price Crossed Below MA(200) Set Alert
MA $SCYX Price Crossed Below MA(13) Set Alert
MA $SCYX Price Crossed Below MA(7) Set Alert
▲ GAP $SCYX Open Gap Up %3 Set Alert
▲ GAP $SCYX Open Gap Up %2 Set Alert
SCYNEXIS, Inc News
SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural ...
Wednesday, January 28, 2026 05:30 AM
This cross-disciplinary meeting highlights the latest discoveries, technologies and translational strategies driving the next generation of antimicrobial solutionsJERSEY CITY, N.J., Jan. 28, 2026 ...
SCYNEXIS Gets FDA QIDP And Fast Track Designations For SCY-247
Wednesday, January 21, 2026 08:16 AM
(RTTNews) - SCYNEXIS, Inc. (SCYX) announced that the U.S. FDA has granted Qualified Infectious Disease Product (QIDP) and Fast Track designations for SCY-247. The QIDP designation provides SCY-247 ...
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Sunday, December 21, 2025 04:00 PM
JERSEY CITY, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and ...
SCYX historical stock data
date open high low close volume
13/02/26 0.81 0.8254 0.75 0.75 416,688
12/02/26 0.7943 0.8141 0.773 0.7771 316,746
11/02/26 0.839 0.8399 0.7802 0.7998 326,924
10/02/26 0.7501 0.8323 0.75 0.8111 603,601
09/02/26 0.76 0.7716 0.7302 0.7505 188,289
06/02/26 0.7104 0.78 0.7003 0.759 213,224
05/02/26 0.71 0.7699 0.6871 0.6904 326,808
04/02/26 0.757 0.7849 0.7247 0.7248 443,695
03/02/26 0.7375 0.79 0.7233 0.757 437,504
02/02/26 0.701 0.7692 0.69 0.7411 415,089
Quote Details
52wk Low:0.565
52wk High:1.31
Vol:416.69K
Avg Vol(3m):7.4M
1Y Chng:-20.45%
1M Chng:+17.46%
Add to Watch List
More Information
Index US Composite
Market Cap. 32.61M